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Abstract 
Because antibiotic resistance occurs in bacteria at an alarming rate, significant 
research has been focused on finding alternative treatments which do not involve the 
use of antibiotics. 
The promotion of beneficial gut bacteria can increase the resistance of animals to 
possible intestinal infections.  
Probiotics can be administered to humans or animals, offering preventive benefits of 
protecting the host from various types of intestinal diseases, providing positive effects 
on digestive processes and stimulating influence on the growth of organism, 
strengthening the barrier function of the gut microbiota and/or non-specific 
enhancement of the immune system. 
A study was designed to screen potential probiotic Bifidobacterium spp. strains with 
the ability to multiply in the intestine of weaned piglets and then to assess their health 
promoting effects when challenged with two enteric pathogens. 
Three series of trials were conducted with 60 weaning pigs fed one of 12 different 
Bifidobacterium spp. strains either once or twice a day. 
The most effective probiotic treatment (Bifidobacterium animalis subsp. lactis, strain 
Ra 18, at a dose of 1011cfu twice a day) was then challenged in two series of 
experiments with the enteric pathogens, Salmonella enterica serovar typhimurium and 
E. coli K88. 
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Bifidobacterium animalis subsp. lactis strain Ra 18 significantly increased (p<0.01) the 
number of viable bifidobacteria in the cecum contents. When it was challenged with 
Salmonella, Ra 18 reduced excretion of this pathogen with the faeces. On the whole, 
supplementation with Ra 18 had a positive effect on the growth performance of pigs 
except after challenge with E. coli K88 where pigs susceptible to ETEC adhesion were 
lighter than pigs not susceptible. 
Introduction  
Infectious diarrhoea of neonatal animals is one of the most common and economically 
devastating conditions encountered in livestock production. 
The infection of pigs with Salmonella enterica serovar typhimurium and 
enterotoxigenic Escherichia coli (ETEC) K88 is associated with enteric disease and 
occurs in pigs from weaning to about 4 months old (Naughton P.J., et al, 2001). 
The potential removal of growth – promoting antibiotics from farm animal feeds has 
led to renewed interest in the use of live microbial cultures (probiotics) as growth 
promoting agents in addition to their current role in controlling enteric disease. 
Probiotics have been used to reduce colonisation of pathogens in the intestines of 
animals and some studies have focused on their anti-infectious effects, particularly the 
inhibition activity against enteropathogens (Zhong S.S., et al 2004). 
It has often been shown that certain lactic acid bacteria within the pig intestinal 
microflora possess an inhibitory activity towards coliform pathogens and the addition 
of large numbers of these bacteria to the porcine microflora in vitro results in a 
consistent and reproducible increase in the rate of removal of the pathogen (Hillman et 
al., 1995). 
In this study we quantified the ability of different strains of Bifidobacterium spp. to grow 
in the intestine of weaned piglets and then assessed the effect of the best probiotic 
treatment in challenge experiments with two strains of enteric pathogens. 
Materials and methods  
A total of 136 pigs (Landrace x Large White) were weaned at 21 days and assigned to 
different treatments based on starting live weight and litter. A good weaning diet was 
designed and all pigs were individually fed. 
The experimental design included 2 phases. In the first phase (probiotic series), the 
probiotic effect of twelve different Bifidobacterium spp. strains from the species B. 
breve, B. suis, B. animalis subsp. lactis and B. choerinum was evaluated. 
The probiotic effect of 3 strains per Bifidobacterium species at the dose of 10
10 cfu was 
assessed in 60 pigs supplied to the pigs either once or twice a day. Four pigs were 
designated as the control group. 
In the second phase (probiotic in challenge tests series), we analysed the effect of the 
best probiotic Bifidobacterium spp. strain on pig growth and health when it was 
challenged with two enteric pathogens which are indicator bacteria for infection risk, 
Salmonella enterica serovar typhimurium and E. coli K88.  
Four groups composed of 8 pigs each were tested in the trial with Salmonella enterica 
serovar typhimurium. The first group (challenge-no additive) each received 1.5 ml of a 3
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solution of the pathogenic Salmonella  (10
9 cfu/ml). The second group (challenge-
bifidobacteria) received Bifidobacterium animalis subsp. lactis (10
11 cfu twice a day) 
and Salmonella. The third group (challenge-atb) received Salmonella and an antibiotic 
(Gentamycin 60 g / 100 kg of feed) and the last group served as a control. 
In the trial with E. coli, three different treatments were tested on 40 weaning pigs. The 
first group of 16 pigs (challenge-no additive) each received 1.5 ml of a broth 
containing 10
9  cfu/ml of E. coli K88. A second group of 16 pigs (challenge- 
bifidobacteria group) received 10
11 cfu of Bifidobacterium animalis subsp. lactis Ra18 
twice a day supplemented in the feed and E. coli K88. The other 8 pigs served as a 
control group. 
In all trials performed, the enumeration of Bifidobacterium spp. and non pathogenic E. 
coli was determined using plate counts with solid selective media. The quantitative 
detection of Bifidobacterium spp. was also performed by dilution PCR method. 
All data were analyzed by SAS. 
Results  
Probiotic series 
Upon evaluation of the effects of different Bifidobacterium spp. strains on 
bifidobacteria counts in the caecum contents, two strains of Bifidobacterium animalis 
subsp. lactis (Ra 18 and M 354) with the highest growth profiles were identified. The 
decision was made to utilise one of these strains, Ra 18, in the subsequent challenge 
trials with enteric pathogens. 
Probiotic in challenge tests series 
Bifidobacterium animalis subsp. lactis Ra 18, identified as the most active treatment in 
the previous series of experiments, demonstrated different effects on the health of the 
pigs when challenged with Salmonella enterica serovar typhimurium and / or 
enterotoxigenic E. coli K88. 
Only in the first challenge with pathogenic Salmonella did the probiotic inocula 
maintain the same growth performance as the pigs not challenged, even if the daily 
weight gain was lower than in pigs fed with the antibiotic (Table 1). The challenge did 
not affect the frequency of diarrhoea, but with the exception of most of the antibiotic-
supplemented subjects, all challenged pigs were positive for the presence of 
Salmonella typhimurium in ileocecal lymph nodes. A low frequency of diarrhoea was 
noted in all groups tested in this series. In the group supplemented with Ra 18, a 
decrease was also observed in the number of pigs which tested positive for 
Salmonella in the faeces. 
In the second trial, when Ra 18 was challenged with E. coli K88, faecal consistency 
was reduced and the addition of the probiotic did not prevent this effect. 
As expected, supplementation with B. animalis subsp. lactis significantly increased the 
viable bifidobacteria in the cecum contents in both experimental series (table 1). 3
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Table.1 Effect of probiotic supplementation on microbiota and on growth performance of already weaned 
pigs (LW=live weight), before and after challenge (Ch) with Salmonella enterica serovar typhimurium (a) or 
with Escherichia coli K88 (b) 
(a) 
Treatment   
Control Challenge Ch+Probiotic Ch+Antibiotic 
SEM 
Starting LW, kg  6.75  6.66  6.81  6.46  3.07 
Final LW, kg  9.79  9.60  10.18  10.15  4.71 
Daily LW gain post-challenge, g  314.8  274.9  299.3  320.2  26.6 
Total daily LW gain, g  187.7  177.5  192.8  221.5  24.7 
LAB (Plate counts, log10 CFU/g of cecum contents)  8.17 8.02  7.80  7.69  0.31 
E. coli (Plate counts, log10 CFU/g of cecum contents)
1  7.31 6.11  6.28  7.01  0.29 
Bifidobacteria (Plate counts, log10 CFU/g of cecum contents)
2  3.90 4.90  6.87  4.96  0.33 
Bifidobacteria (Quantitative PCR, log10 CFU/g of cecum contents )  7.85 8,23  8.43  8.22  0.36 
1 Effect of challenge, P <0.05; Antibiotic vs no supplement, P <0.05. 
2 Effect of challenge, P <0.01; Probiotic vs no supplement, P <0.01. 
 
(b) 
 
Treatment   
Control Challenge  Ch+Probiotic 
SEM
 
Starting LW, Kg  6.46  6.62  6.77  3.20 
Final LW, g  7.98  8.05  8.24  3.48 
Daily LW gain post-challenge, g  186.9  182.2  196.9  28.5 
Total daily LW gain, g  109.0  102.5  104.7  16.0 
LAB (Plate counts, log10 CFU/g of cecum contents)  8.61 8.10  8.40  0.17 
E. coli (Plate counts, log10 CFU/g of cecum contents)  5.93 6.77  6.57  0.24
1 
Bifidobacteria (Plate counts, log10 CFU/g of cecum contents) 4.70  4.98 7.18 0.22
2 
Bifidobacteria (Quantitative PCR, log10 CFU/g of cecum contents) 7.34  7.04  8.89  0.25
3 
1 Co vs (Ch+Pr), P<0.05. 
2 Co vs (Ch+Pr), P<0.01; Ch vs Pr, P<0.01. 
3 Co vs (Ch+Pr), P=0.085; Ch vs Pr, P<0.01. 
Discussion 
Post - weaning diarrhoea associated with enteric pathogens, E. coli and Salmonella, is 
a major disease in pig husbandry during the first 2 weeks post weaning. To prevent 
this condition, serious consideration should be given to probiotic supplementation with 
the feed. However, results obtained in experiments conducted to date has been 
variable. 
Although the mechanism of action of probiotics is not well understood, it is generally 
accepted that probiotics exert their influence on the host by the intestinal microbiota 
(Biavati, B., et al., 2000). 
Therefore, the ability of 12 Bifidobacterium spp. strains to grow and persist in the 
intestine of weaned piglets was investigated.  The most active treatment identified was 
then challenged against the two enteric pathogens.  
The results demonstrate that the same strain may have variable effects on the health 
of different hosts. 
In the first trial, the most promising probiotic treatment identified (B. animalis subsp. 
lactis Ra 18) showed the greatest ability to multiply in the intestine of weaning piglets, 3
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affecting their daily weight gain. This was even the case when challenged with 
Salmonella. However, the same strain, when administered with E. coli K 88,   
increased the number of viable bifidobacteria cells in the cecum contents but did not 
induce other probiotic effects. 
Conclusions  
Dietary manipulation using probiotic preparations is claimed to have potential for 
improvements in health and performance in growing pigs (Collier C.T., et al., 2003). 
Strain selection and dose of supplementation need to be considered with this 
approach. 
The results of this study support the concept that supplementation with probiotics as 
alternatives to antibiotics might ideally promote the growth of beneficial commensal 
bacteria while suppressing those that are deleterious. 
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